Bioassociate is the only firm in Israel that utilizes unique models for the valuation of life science companies, mutually developed with leading international firms. These methods take into account the uniqueness of the industry and the distinctive factors that influence valuation of life science companies.

We apply advanced research and analysis methods of life science companies, which rely on deep understanding of the science and technology, along with comprehensive evaluation of regulatory pathways and the business environment, including market trends and demands.

Research teams at Bioassociate are comprised of expert scientific analysts who have a deep understanding and familiarity of the industry, along with financial analysts who are proficient in implementing life-science-specific valuation models, developed jointly with leading international firms.

Information is gathered by reviewing a company’s technology, development programs, regulatory pathways, as well as financial disclosures and trading history. Competitor analysis (market and pipeline), industry information databases and one-on-one interviews with the company’s management are used by Bioassociate’s analysts to gain a comprehensive understanding about the business.

Following extensive analytical research, an in-depth initial report is written on the company. This analysis is then followed by quarterly updates and breaking updates following substantial announcements by the company.